Group items tagged

The purpose of this Funding Opportunity Announcement (FOA) is to encourage biomedical, behavioral, and social science research that will inform the development and evaluation of regulations on tobacco product manufacturing, distribution, and marketing.

This Funding Opportunity Announcement (FOA) solicits applications that propose research designed to test assumptions and hypotheses on the role of social and behavioral factors in interventions intended to increase interest, motivation and preparedness for careers in biomedical and behavioral research. These research findings should guide the design and implementation of potential interventions.

The NIH Director's Transformative Research Awards complement NIHs traditional, investigator-initiated grant programs by supporting individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original and/or unconventional research with the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies. Little or no preliminary data are expected. Projects must clearly demonstrate the potential to produce a major impact in a broad area of biomedical or behavioral research.

The overall goal of the NIH Research Career Development program is to help ensure that a diverse pool of highly trained scientists is available in appropriate scientific disciplines to address the Nation's biomedical, behavioral, and clinical research needs. In addition to this opportunity, NIH Institutes and Centers (ICs) support a variety of other mentored career development programs designed to foster the transition of new investigators to research independence. These other programs may be more suitable for particular candidates.  NIH also supports non-mentored career development programs for independent investigators. More information about Career programs may be found at the NIH Extramural Training Mechanisms website.

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIDA R25 program is to support educational activities that enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development.

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH.  The over-arching goal of this NIGMS R25 program is to support educational activities that complement and/or enhance the research training of a workforce to meet the nation's biomedical, behavioral and clinical research needs.  

The mission of the Society of Family Planning Research Fund is to support interdisciplinary research in the biological, medical, epidemiological, behavioral, and social sciences related to family planning. The society focuses on a wide range of research areas - from improvements in basic conceptual or biomedical knowledge, to design of programs or policies that will provide family planning more safely, efficiently and extensively, to studies of the social and psychological dimensions of family planning services and programs.

Leidos will match high-scoring, unfunded National Institutes of Health (NIH) proposals with private biomedical foundations and/or industries seeking to fund promising research. Foundations will have access to peer-reviewed research proposals that directly relate to their funding priorities, industry will have access to a rich pipeline of early stage and translational research proposals that align with its priorities, while applicants with strong research proposals will be provided with a second opportunity to secure funding. The foundations, industries, applicants, and NIH all will benefit from this synergy.

This award is designed to support young scientists just embarking on their independent research careers.  The applicants' research interests should be consonant with those of the March of Dimes' mission: The  Mission of the March of Dimes is to improve the health of babies by preventing birth defects, premature birth and infant mortality. The March of Dimes defines a birth defect as any abnormality of structure or function, whether inherited, or acquired in utero and presenting in infancy or early childhood. Deviations from reproductive health of women and men as an underlying basis of birth defects, i.e. preconceptional events, perinatal course, and premature births, are appropriate subjects for research support. Relevance is interpreted broadly to include fundamental cell biology (embryogenesis, cell lineage, differentiation), genetics and genomics, fundamental cellular and clinical pathogenesis of disorders of importance to mothers and infants, biomedical engineering and imaging, and social and behavioral aspects. Each application should be accompanied by a Letter of Support from a Nominator (see below). The award is $150,000 for two years, including 10 percent indirect costs to sponsoring institutions.

The National Institutes of Health (NIH) Exploratory/Developmental Grant (R21) funding opportunity supports the development of new research activities in categorical program areas. The R21 activity code is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research.

The NIH Directors New Innovator (DP2) Award initiative supports a small number of early stage investigators of exceptional creativity who propose bold and highly innovative new research approaches that have the potential to produce a major impact on broad, important problems in biomedical and behavioral research. The New Innovator Award initiative complements ongoing efforts by NIH and its Institutes and Centers to fund early stage investigators through R01 grants, which continue to be the major sources of NIH support for early stage investigators. The NIH Directors New Innovator Award initiative is a component of the High Risk - High Reward Research Program of the NIH Common Fund.

This Funding Opportunity Announcement (FOA) encourages Research Education Grant (R25) applications from institutions that propose to enhance the pool of masters degree students from underrepresented backgrounds who are trained and available to participate in NIH-funded research. This initiative promotes partnerships/consortia between colleges or universities granting a terminal masters degree with institutions that offer the doctorate degree. The program expects that the joint efforts of doctorate degree-granting and masters degree-granting institutions will foster the development of a well-integrated institutional program that will provide students with the necessary academic preparation and skills to enable their transition and successful completion of the Ph.D. degree in biomedical and behavioral sciences.

The National Institutes of Health (NIH) will award Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32) to eligible, domestic institutions to enhance predoctoral and postdoctoral research training, including short-term research training, and help ensure that a diverse and highly trained workforce is available to meet the needs of the Nations biomedical, behavioral, and clinical research agenda. Research training programs will incorporate didactic, research, and career development components to prepare individuals for careers that will have a significant impact on the health-related research needs of the Nation. 

The purpose of this Funding Opportunity Announcement (FOA) is to enhance the diversity of the mental health research workforce by providing dissertation awards in all research areas within the strategic priorities of the NIMH to individuals from diverse backgrounds underrepresented in biomedical, behavioral, clinical and social sciences research. This two-year award supports the completion of the doctoral research project.

he NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The goal of this NHLBI R25 program is to enhance the diversity of the biomedical, behavioral and clinical research workforce . To this end, this funding opportunity announcement encourages the development of creative educational activities with a primary focus on Research Experiences, Courses for Skills Development and Mentoring Activities.

The goal of this NIEHS undergraduate research education R25 program is to support educational activities that enhance the diversity of the biomedical, behavioral and clinical research workforce in the environmental health sciences. To this end, this funding opportunity announcement (FOA) encourages the development of creative educational activities with a primary focus on research experiences for undergraduates at the junior and senior level.

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The goal of this NHLBI R25 program is to support educational activities that enhance the diversity of the biomedical, behavioral, and clinical research workforce in the mission areas of importance to NHLBI. To accomplish the stated goal, this funding opportunity announcement encourages the development of creative educational activities with a primary focus on Research Experiences.

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The goal of this NHLBI R25 program is to support educational activities that enhance the diversity of the biomedical, behavioral, and clinical research workforce in the mission areas of importance to NHLBI. To accomplish the stated goal, this funding opportunity announcement encourages the development of creative educational activities with a primary focus on Research Experiences.

This Funding Opportunity Announcement (FOA) invites grant applications from institutions/organizations that propose to build research infrastructure to promote external collaboration with the medical rehabilitation community. The aim of this FOA is to create a national network of research cores that provide access to collateral expertise in biomedical, behavioral, engineering, and/or psychosocial fields that is particularly relevant to medical rehabilitation research. We are particularly interested in supporting infrastructure programs in clinical trial design, engineering and the environment, individualized medical rehabilitation and dynamic reassessment, and applied behavioral supports for rehabilitation research and healthy outcomes. However, other areas of expertise may be proposed provided they offer unique research opportunities and have potential for promoting medical rehabilitation research and improving outcomes for people with disabilities. In response to this FOA, applicants should propose a program of research resources and collaborative opportunities in a specific research domain. This may be accomplished through a workshops, written material, and websites, consultations, collaborations, and pilot funding. In addition, the research core may support activities within the grantee institution related to technique development, adaptation, and validation. To accomplish the aims of the FOA, applicants may propose collaborations to other institutional sites, provided that they cover the appropriate administrative and logistical issues.

The National Cancer Institute (NCI) Exploratory/Developmental Grant (R21) funding opportunity supports the development of new research activities in all areas of cancer research. The R21 mechanism is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (biomedical, behavioral, or clinical).